LUPIN LIMITED

Established Year: 1968
Main Product Category: HEALTH & BEAUTY PRODUCTS Health and Medical Products
Products: Pharmaceutical Products (Prescription Pharmaceuticals, Over-the-Counter Drugs)
Brands: ANTARA, SUPRAX, ALINIA, INSPIRACHAMBER, ZAXINE, RELISTOR, MONODOX, CELEBREX, LUPIFIL, YAZ, LUNESTA, DIOVAN, EXFORGE, EPIVIR, MINASTRIN, ZORVOLEX, PRADAXA, LATUDA, ANGELIQ
Number of Employees: 15000
Key Executives: Mr. Desh Bandhu Gupta - Founder and Chairman
Ms. Vinita Gupta - Chief Executive Officer
Certificates achieved: ISO 14001, ISO 18001
Export Markets: United States, Japan, Australia, European Union countries, South Africa, Philippines, Switzerland, Canada, Mexico, Malaysia, Brazil, Russia, China, United Arab Emirates
Stocks Listed: Stocks of LUPIN LIMITED are listed on National Stock Exchange of India (NSE) under ticker LUPIN.
Stocks of LUPIN LIMITED are listed on Bombay Stock Exchange (BSE) under ticker 500257.
Wikipedia: LUPIN LIMITED's page on Wikipedia
Bloomberg: LUPIN LIMITED's profile on Bloomberg
Additional Information:

Lupin Limited is the 7th largest generic pharmaceutical company globally by market capitalization and the 10th largest generic pharmaceutical company globally by sales.

News and articles related to the company LUPIN LIMITED:

• Indian drugmakers may suffer profit drop as coronavirus threatens China supplies
• Lupin seeks to pare new drug costs with string of licensing deals
• Lupin joins hands with Boehringer to sell new oral anti-diabetic drugs
• Lupin aims to resolve quality issues highlighted by FDA in 12-15 months
• Lupin to buy branded drugs from Shionogi in Japan expansion

More news & articles >>>